Downstream Versus Upstream Strategy for the Administration of P2Y12 Receptor Blockers

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 2520 participants.

Also called NCT02618837

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose diagnostic
Phase
Phase 4
Enrolled
  • 2,520 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02618837
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02618837. Randomized; no masking; primary purpose diagnostic. Start 2015-12-14 (actual); primary completion 2021-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Downstream Versus Upstream Strategy for the Administration of P2Y12 Receptor Blockers
Acronym
DUBIUS
Condition
Unstable Angina or Non ST Elevated Myocardial Infarction
Intervention (Procedure)
Downstream strategy
Intervention (Procedure)
Upstream strategy
Lead sponsor
University of Padova (class: other)
Collaborator
Azienda Ospedaliera di Padova (class: other)

Record details

Record id
cardio:ct-nct02618837
Content hash
bbd59e8609598a372627046668aa616d61fa2503aa8bc497b1d1399d7c72eebc